Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07365566

Pain Assessment in Patients With Idiopathic Rapid Eye Movement (REM) Sleep Behaviour Disorder

Led by University Hospital, Toulouse · Updated on 2026-05-01

24

Participants Needed

1

Research Sites

22 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease, with over 12 million patients expected globally by 2040. The disease is currently diagnosed at the appearance of motor symptoms, but by then, over 60% of striatal dopaminergic neurons have already been destroyed. Prodromal symptoms such as idiopathic REM Sleep Behavior Disorder (iRBD), anosmia, mood disorders and constipation appear earlier and are listed as criteria for a prodromal PD diagnosis. Identifying early signs is critical to initiate neuroprotective treatments as early as possible. While pain is prevalent and highly disabling in early PD, no data are currently available on pain perception in iRBD patients, whose condition is of the main risk factor for PD development.

CONDITIONS

Official Title

Pain Assessment in Patients With Idiopathic Rapid Eye Movement (REM) Sleep Behaviour Disorder

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with idiopathic REM Sleep Behavior Disorder confirmed by polysomnography
  • No clinical diagnosis of Parkinson's disease or other neurodegenerative diseases
  • Ability to understand and complete study procedures and questionnaires
  • For control group: diagnosed with narcolepsy type 1
  • Control group with coexisting REM sleep behavior disorder confirmed by polysomnography
  • Control group able to understand and complete study procedures and questionnaires
Not Eligible

You will not qualify if you...

  • Diagnosed Parkinson's Disease, dementia with Lewy bodies or multiple system atrophy
  • Severe depression according to DSM V
  • Inability to complete study procedures or questionnaires

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Centre Expert Parkinson Hôpital Pierre Paul Riquet Place du Docteur Baylac

Toulouse, France, 31059

Actively Recruiting

Loading map...

Research Team

C

Christine BREFEL COURBON

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here